Image 8_Gauging public perceptions of military and police roles in US domestic pandemic response during COVID-19.jpeg by Evan Warren (21566750)

“…</p>Results<p>A majority were complimentary of and comfortable with these armed actors' role in the response and supportive of involvement in future crises, with the military regarded more favorably than police. …”

Image 6_Gauging public perceptions of military and police roles in US domestic pandemic response during COVID-19.jpeg by Evan Warren (21566750)

“…</p>Results<p>A majority were complimentary of and comfortable with these armed actors' role in the response and supportive of involvement in future crises, with the military regarded more favorably than police. …”

Image 5_Gauging public perceptions of military and police roles in US domestic pandemic response during COVID-19.jpeg by Evan Warren (21566750)

“…</p>Results<p>A majority were complimentary of and comfortable with these armed actors' role in the response and supportive of involvement in future crises, with the military regarded more favorably than police. …”

Image 1_Gauging public perceptions of military and police roles in US domestic pandemic response during COVID-19.jpeg by Evan Warren (21566750)

“…</p>Results<p>A majority were complimentary of and comfortable with these armed actors' role in the response and supportive of involvement in future crises, with the military regarded more favorably than police. …”

Image 2_Gauging public perceptions of military and police roles in US domestic pandemic response during COVID-19.jpeg by Evan Warren (21566750)

“…</p>Results<p>A majority were complimentary of and comfortable with these armed actors' role in the response and supportive of involvement in future crises, with the military regarded more favorably than police. …”

Image 4_Gauging public perceptions of military and police roles in US domestic pandemic response during COVID-19.jpeg by Evan Warren (21566750)

“…</p>Results<p>A majority were complimentary of and comfortable with these armed actors' role in the response and supportive of involvement in future crises, with the military regarded more favorably than police. …”

Table_4_Timing of Repetitive Transcranial Magnetic Stimulation Onset for Upper Limb Function After Stroke: A Systematic Review and Meta-Analysis.DOCX by Eline C. C. van Lieshout (6638819)

“…</p><p>Results: We included 38 studies involving 1,074 stroke patients. Subgroup analysis demonstrated benefit of rTMS applied within the first month post-stroke [MD = 9.31; 95% confidence interval (6.27–12.34); P < 0.0001], but not in the early subacute phase (1–3 months post-stroke) [MD = 1.14; 95% confidence interval (−5.32 to 7.59), P = 0.73) or chronic phase (>6 months post-stroke) [MD = 1.79; 95% confidence interval (−2.00 to 5.59]; P = 0.35), when assessed with a function test [Fugl-Meyer Arm test (FMA)]. …”

Data Sheet 1_Association between maternal khat use and other determinants and low birth weight in Halaba Zone, South Ethiopia: an unmatched case–control study.docx by Biruk Wogayehu (7470719)

“…Suggested strategies involve the early identification and management of identified modifiable variables. …”

C–H Bond Oxidation Catalyzed by an Imine-Based Iron Complex: A Mechanistic Insight by Giorgio Olivo (1497448)

“…Experimental evidence is provided that reactions involve initial oxidation of the complexes to the ferric state, and it is proposed that a ligand arm dissociates to enable hydrogen peroxide binding and activation. …”

Table_1_Timing of Repetitive Transcranial Magnetic Stimulation Onset for Upper Limb Function After Stroke: A Systematic Review and Meta-Analysis.DOCX by Eline C. C. van Lieshout (6638819)

“…</p><p>Results: We included 38 studies involving 1,074 stroke patients. Subgroup analysis demonstrated benefit of rTMS applied within the first month post-stroke [MD = 9.31; 95% confidence interval (6.27–12.34); P < 0.0001], but not in the early subacute phase (1–3 months post-stroke) [MD = 1.14; 95% confidence interval (−5.32 to 7.59), P = 0.73) or chronic phase (>6 months post-stroke) [MD = 1.79; 95% confidence interval (−2.00 to 5.59]; P = 0.35), when assessed with a function test [Fugl-Meyer Arm test (FMA)]. …”

Image_2_Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy.jpeg by FNU Deepika (11881310)

“…</p>Methods<p>This is a secondary analysis of a single-arm, open-label clinical trial (NCT01378299) on pharmacogenetics of response to T therapy conducted between 2011 and 2016 involving 105 men (40–74 years old), with average morning T < 300 ng/dl, given intramuscular T cypionate 200 mg every 2 weeks for 18 months. …”

Table_3_Timing of Repetitive Transcranial Magnetic Stimulation Onset for Upper Limb Function After Stroke: A Systematic Review and Meta-Analysis.DOCX by Eline C. C. van Lieshout (6638819)

“…</p><p>Results: We included 38 studies involving 1,074 stroke patients. Subgroup analysis demonstrated benefit of rTMS applied within the first month post-stroke [MD = 9.31; 95% confidence interval (6.27–12.34); P < 0.0001], but not in the early subacute phase (1–3 months post-stroke) [MD = 1.14; 95% confidence interval (−5.32 to 7.59), P = 0.73) or chronic phase (>6 months post-stroke) [MD = 1.79; 95% confidence interval (−2.00 to 5.59]; P = 0.35), when assessed with a function test [Fugl-Meyer Arm test (FMA)]. …”

Table_5_Timing of Repetitive Transcranial Magnetic Stimulation Onset for Upper Limb Function After Stroke: A Systematic Review and Meta-Analysis.DOCX by Eline C. C. van Lieshout (6638819)

“…</p><p>Results: We included 38 studies involving 1,074 stroke patients. Subgroup analysis demonstrated benefit of rTMS applied within the first month post-stroke [MD = 9.31; 95% confidence interval (6.27–12.34); P < 0.0001], but not in the early subacute phase (1–3 months post-stroke) [MD = 1.14; 95% confidence interval (−5.32 to 7.59), P = 0.73) or chronic phase (>6 months post-stroke) [MD = 1.79; 95% confidence interval (−2.00 to 5.59]; P = 0.35), when assessed with a function test [Fugl-Meyer Arm test (FMA)]. …”

Eradication of <i>Helicobacter pylori</i> Infection Improves Levodopa Action, Clinical Symptoms and Quality of Life in Patients with Parkinson's Disease by Hasriza Hashim (663749)

“…</p><p>Methods</p><p>A prospective study involving idiopathic PD patients on levodopa therapy. …”

Supplementary Material for: Renal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis by Stavas J. (14318463)

“…<b><i>Conclusion:</i></b> Trials that include patients with an eGFR of <20 mL/min/1.73 m² are uncommon, and none to date involve autologous homologous cell-based treatments. …”

Image_1_Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy.jpeg by FNU Deepika (11881310)

“…</p>Methods<p>This is a secondary analysis of a single-arm, open-label clinical trial (NCT01378299) on pharmacogenetics of response to T therapy conducted between 2011 and 2016 involving 105 men (40–74 years old), with average morning T < 300 ng/dl, given intramuscular T cypionate 200 mg every 2 weeks for 18 months. …”

Data_Sheet_1_Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: A systematic review and meta-analysis.pdf by Jinghua Shi (252041)

“…</p>Results<p>A total of 11 studies involving 2,251 participants with dysmenorrhea were included. …”

Exogenous DNA-damaging agents induce closely spaced mutations in ssDNA. by Natalya P. Degtyareva (6681245)

“…Midchromosome reporter: <i>CAN1</i>, <i>URA3</i>, and <i>ADE2</i> genes were placed in the middle of the right arm of Chromosome II, more than 300 kb away from either telomere. …”

Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity... by Hiroko Kasai (11730272)

“…Patients with less involvement of IgE in the pathogenesis and inadequate remission induction by TCS may not be expected to respond well to TCI proactive therapy.Key messages</p><p>AD patients can be stratified into three types according to their pattern of responsiveness to TCI proactive therapy.…”

Table_2_Timing of Repetitive Transcranial Magnetic Stimulation Onset for Upper Limb Function After Stroke: A Systematic Review and Meta-Analysis.DOCX by Eline C. C. van Lieshout (6638819)

“…</p><p>Results: We included 38 studies involving 1,074 stroke patients. Subgroup analysis demonstrated benefit of rTMS applied within the first month post-stroke [MD = 9.31; 95% confidence interval (6.27–12.34); P < 0.0001], but not in the early subacute phase (1–3 months post-stroke) [MD = 1.14; 95% confidence interval (−5.32 to 7.59), P = 0.73) or chronic phase (>6 months post-stroke) [MD = 1.79; 95% confidence interval (−2.00 to 5.59]; P = 0.35), when assessed with a function test [Fugl-Meyer Arm test (FMA)]. …”